Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Corinne Hanotin0
Umesh Chaudhari0
Laurence Bessac0
Date of Patent
February 7, 2017
Patent Application Number
13982373
Date Filed
January 27, 2012
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to methods for treating diseases or conditions in which proprotein convertase subtilisin/kexin type 9 (PCSK9) expression or activity causes an impact by administration of PCSK9-specific antibodies or antigen-binding fragments thereof and preferably by additional administration of an inhibitor of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA reductase). The present invention further relates to PCSK9-specific antibodies or antigen-binding fragments thereof for use in the treatment of diseases or conditions in which PCSK9 expression or activity causes an impact.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
